-
Study aim
-
Effect of Combined serum (betamethasone, dexamethasone, bromhexine N/S) with fluticasone spray and N/S on 200 postoperative CRS patients with polyposis after FESS surgery
-
Design
-
controlled, single-blind, randomized, phase 2 clinical trial on 200 patients. The rand function of Excel software was used.
-
Settings and conduct
-
In this study, all patients referred to the clinic of Masih-Daneshvari Hospital with the diagnosis of chronic rhinosinusitis and polyposis will be divided into two randomized groups. None of the patients know the group they will be in, but the research team will be aware of it and the type of treatment. Patients will come back to the clinic one week after the surgery and according to the type of their group, they will receive the relevant interventional treatment for 3 weeks. Also, the Persian version of the SNOT-22 questionnaire, whose validity and reliability have been confirmed, will be used before and after the treatment. A questionnaire that measures the quality of life related to nose and sinus diseases with total scores between 0 and 110 and each item is graded on 6 levels (0-5).
-
Participants/Inclusion and exclusion criteria
-
Including criteria: Patients aged 18 to 70 with chronic rhinosinusitis who undergo endoscopic surgery due to nasal polyposis.
Excluding criteria: Asthma, Severe systemic problems such as Heart Failure and Diabetes, Pregnancy, Cystic Fibrosis, Malignancies
-
Intervention groups
-
In the first group, at first, 10CC of mixed serum (one ampoule of betamethasone, dexamethasone, and bromhexine dissolved in a liter of normal saline washing serum) was poured into each nostril, then repeated every 12 hours. In the second group, at first 10CC normal saline serum was poured into each nostril, then fluticasone sprays 1 puff every 12 hours will be used.
-
Main outcome variables
-
Age, gender, endoscopic status, quality of life; before and after treatment